Week 119 Review - In brief

Although I said there wouldn't be a review for a few weeks I did capture snapshots while I was on hols, so can complete the picture, although with a little less detail than normal and no graphs.

This wasn't a great week, with the combined portfolios dropping by £759 with a total value of £78,530 and buffer between cost and value of £7,466.

Worst performer was TLOU:Tlou Energy dropping 14% but that was just profit taking. REDS:RedstoneConnect goes from bad to worse in the trading account, dropping 8% to go 46% down on purchase price. JLP:Jubilee Platinum and AMYT:Amryt Pharma both had a wobble, dropping 7%.

CAML:Central Asia Metals is doing great since the announced reverse takeover and climbed another 6% this week to go 49% up overall.

Share of the Week is IQE:IQE which climbed 8% in my SIPP and a massive 36% against cost price in my ISA.

			Weekly Change
Cash	£53.61		+£7.43
Portfolio cost	£44,426.84		+£0
Portfolio sell value (bid price - commission)	£49,162.52	(+10.7%)	-£787.17
Potential profits	£11,255.76		+£371.42
Yr 3 Dividends	£17.77		+£7.43
Yr 3 Profit from sales	£585.38		+£0
Yr 3 Average monthly cash profit	£157.99	(4.3%)	-£8.98
Total Dividends	£1,196.82		+£7.43
Total Profit from sales	£7,297.85		+£0
Average monthly cash profit	£305.08	(8.2%)	-£2.32
(Sold stocks profit + Dividends - Fees / Months)

A dividend of £7.43 from TND:Tandem Group arrived. OPTI:Optibiotix dropping 2p negated all the increases in profits from IQE:IQE.

The SIPP looks like this after week 103

			Weekly Change
Cash	£19.31		-+£0
Portfolio cost	£26,007.03		+£0
Portfolio sell value (bid price - commission)	£28,962.21	(11.4%)	+£69.18
Potential profits	£4,340.10		+£76.92
Yr 2 Dividends	£502.91		+£0
Yr 2 Profit from sales	£6,575.33		+£0
Yr 2 Average monthly cash profit	£593.17	(27.4%)	-£11.87
Total Dividends	£916.10		+£0
Total Profit from sales	£8,925.19		+£0
Average monthly cash profit	£407.82	(18.8%)	-£4.00
(Sold stocks profit + Dividends - Fees / Months)

All pretty flat with OPTI:Optibiotix losses matched by good gains for CAML:Central Asia Metals and IQE:IQE.

The Trading account looks like this after Week 69

			Weekly Change
Cash	£79.63		+£0
Portfolio cost	£486.05		+£0
Portfolio sell value (bid price - commission)	£260.49	(-46.4%)	-£41.70
Potential profits	£0		+£0
Dividends	£1.15		+£0
Profit from sales	-£22.85		+£0
Average monthly cash profit	-£1.36	(-3.4%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

Worse and worse...

That's it - just a quickie and now on to a more detailed review of week 120...

Week 118 Review - IQE soars!

I got home from work yesterday and saw an RNS alert from IQE:IQE posted after hours. When I opened it and read there was to be a placing causing 10% dilution I was dismayed. The more I read the less dismayed and more excited I became. The placing was to fund a massive ramp up in production to meet the demand "from a leading global consumer electronics company for use in one of its mass market consumer products". This surely has to be Apple.

The dismay turned to elation when I read the placing was for the current share price and the institutions were locked in for 3 months. All those shorters counting on it going lower, and now 67 million shares sold at 140p - surely it's unlikely the price will drop below that now?

This morning it all came together as the share price soared. I anticipated a pull-back but it never came, with the price finishing 23p up on yesterday. My ISA holding was bought at 29.59p so that meant a 77.7% rise in a day!

Up until that point it had been a terrible week, but IQE:IQE has saved it big-style. The combined portfolios finished up by £902 at a total value of £79,290 and the buffer between cost and value up to £8,226. Maybe not all Fridays are bad!

Lots of smaller losses this week, including another 1p off OPTI:Optibiotix, but by far the worst performer was MTFB:Motif Bio, dropping 11% and in severe danger of going back into loss as people lose patience and take profits.

I'm torn over Share of the Week this week, as IQE:IQE has had such a wonderful day and saved my week from being well in the red. However, with the SIPP up 11% and the ISA up 49% it suffered from having a less successful start to the week so today was a bit of a recovery. Granted I'm over the moon at total potential profits of £9,276 despite already cashing in £4,978, and my original ISA holding is now 446% up on cost price. However, there's one share that beat it this week.

TLOU:Tlou Energy rose an incredible 42% this week and I don't really know why. It's now up by 60% on purchase price and making potential profits of £832. I think the potential is getting recognised by more people, and if the tender is won for the power station then it could really fly.

Onwards and upwards

The ISA and share portfolios look like this

			Weekly Change
Cash	£46.18		-£3.75
Portfolio cost	£44,426.84		+£0
Portfolio sell value (bid price - commission)	£49,949.69	(+12.4%)	+£856.51
Potential profits	£10,884.34		+£1,200.15
Yr 3 Dividends	£10.34		+£0
Yr 3 Profit from sales	£585.38		+£0
Yr 3 Average monthly cash profit	£166.97	(4.5%)	-£14.09
Total Dividends	£1,189.39		+£0
Total Profit from sales	£7,297.85		+£0
Average monthly cash profit	£307.40	(8.3%)	-£2.76
(Sold stocks profit + Dividends - Fees / Months)

Cash down due to ISA charge. Potential profits up by £1,200 mainly thanks to IQE:IQE but lots of deepening losses took £350 of that away as the sell price rose by a lower £856.

That'll do nicely for a few weeks thank you.

The SIPP looks like this after week 102

			Weekly Change
Cash	£19.31		-£10.88
Portfolio cost	£26,007.03		+£0
Portfolio sell value (bid price - commission)	£28,893.03	(11.1%)	+£62.34
Potential profits	£4,263.18		+£82.01
Yr 2 Dividends	£502.91		+£0
Yr 2 Profit from sales	£6,575.33		+£0
Yr 2 Average monthly cash profit	£605.04	(27.9%)	-£13.31
Total Dividends	£916.10		+£0
Total Profit from sales	£8,925.19		+£0
Average monthly cash profit	£411.82	(19.0%)	-£4.54
(Sold stocks profit + Dividends - Fees / Months)

£10.88 vanished from cash as SIPP fees, profit just sneaked up a little thanks to IQE:IQE but almost nullified by drops in LGEN:Legal & General and OPTI:Optibiotix. CAML:Central Asia Metals climbed a little to help out.

The rise has been very shallow over the last few weeks, but it is heading upwards.

The trading account looks like this after week 68

			Weekly Change
Cash	£79.63		+£0
Portfolio cost	£486.05		+£0
Portfolio sell value (bid price - commission)	£302.19	(-37.8%)	-£16.68
Potential profits	£0		+£0
Dividends	£1.15		+£0
Profit from sales	-£22.85		+£0
Average monthly cash profit	-£1.38	(-3.4%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

It's just a relentless drip downwards - dull, dull, dull, dull, dull

Dull, dull, dull, dull, dull

So Friday saved the week, and all is well. I don't care what's happening next week as I'm off to Costa Rica. Hopefully I'll get connectivity to take the weekly snapshots so the graphs don't look odd, but the next update will be week 121.

Week 117 Review - Tiny rise despite most shares dropping

It's been a frustrating week, with small drops in value of the majority of my holdings. Somehow the week ended up in the black as the rises in CWR:Ceres Power, IQE:IQE and JLP:Jubilee Platinum were just enough to counter all the drops.

Worst performer was RED:RedT Energy. This has been doing well lately, but has fallen back to loss dropping 12% this week. It's only 5% down so could yo-yo between profit and loss until the next big news.

RDT:Rosslyn Data feels like it's dying a slow death, dropping another 7% and now losing 70%. That will teach me to buy shares in a startup tech company without doing enough research and spotting that the board members with the commercial nous had left the company. Never mind, I only invested £375 as a feeler with the aim of topping up as the story unfolded, which it didn't.

SBTX:SkinBioTherapeutics dropped another 6% and is now losing 32% which is very annoying given the trouble I went to buy shares on IPO day. I reckon it could be a year until these break even as it's going to take a while to get to the point where deals can be made, but I suppose there's the promise of a load of free shares from OPTI:Optibiotix which would automatically put this in profit when they arrive.

AMYT:Amryt Pharma was over £1,000 in profit a few months ago. This week it dropped by 3% and is now at a loss. Deeply upsetting watching all that money vanish, but I still prefer long-term holding rather than trying to sell and buy back. I've demonstrated how bad I am at doing that with my trading account!

Precious little good news this week. As mentioned in the intro, JLP:Jubilee Platinum rose by 3% which was a healthy contribution, and CWR:Ceres Power Holdings climbed 6% to go 53% up. I think this is in anticipation of some big deal either for data centres or electric cars - we shall see.

Share of the Week is IQE:IQE which only climbed 4% in my SIPP but 16% in my ISA to take it 397% up on purchase price. At one point it was over 400% up, but dropped off on Friday. Huge demand for the iPhone X will no doubt help in the short term, but there are much more exciting developments ahead.

For the first week in ages OPTI:Optibiotix had no impact on the portfolio performance as is stayed the same price despite announcing a massive contract with a subsidiary of Premier Foods. How this is being held back I really do not know. Deals with Sacco, Tata, Nutrilinea, HLH BioPharma, Cereal Ingredients Inc among others and now Premier Foods will put OPTI:Optibiotix ingredients in products that sell all over the globe.

Stable

Here's the performance of the ISA and share accounts

			Weekly Change
Cash	£49.93		+£0
Portfolio cost	£44,426.84		+£0
Portfolio sell value (bid price - commission)	£49,093.18	(+10.5%)	-£68.59
Potential profits	£9,684.19		+£138.94
Yr 3 Dividends	£10.34		+£0
Yr 3 Profit from sales	£585.38		+£0
Yr 3 Average monthly cash profit	£181.06	(4.9%)	-£15.09
Total Dividends	£1,189.39		+£0
Total Profit from sales	£7,297.85		+£0
Average monthly cash profit	£310.16	(8.4%)	-£2.68
(Sold stocks profit + Dividends - Fees / Months)

Potential profits were up thanks the the shares mentioned in the intro, but losses deepened by more, not helped by both RED:RedT Enegy and AMYT:Amryt Pharma going from profit to loss.

It looks flat so I'll just make believe it didn't go down

The SIPP looks like this after week 101

			Weekly Change
Cash	£30.19		-£788.51
Portfolio cost	£26,007.03		+£788.52
Portfolio sell value (bid price - commission)	£28,830.69	(10.9%)	+£130.95
Potential profits	£4,181.17		+£111.30
Yr 2 Dividends	£502.91		+£0
Yr 2 Profit from sales	£6,575.33		+£0
Yr 2 Average monthly cash profit	£618.35	(28.5%)	-£12.88
Total Dividends	£916.10		+£0
Total Profit from sales	£8,925.19		+£0
Average monthly cash profit	£416.36	(19.2%)	-£4.16
(Sold stocks profit + Dividends - Fees / Months)

I invested the tax rebate and CAML:Central Asia Metals dividend in OPTI:Optibiotix on Monday, so the cash value went down and the portfolio cost went up. The 1p difference must be a cumulative rounding error from adding 73.33p times 1,059 to the price per share, bringing it up to 65.04464p.

Profits were mainly up thanks to IQE:IQE but tiny rises in LGEN:Legal & General and CAML:Central Asia Metals helped offset the small dip caused by the spread from buying OPTI:Optibiotix.

Looking at the average monthly profits now the SIPP is almost 2 years old and the other accounts are past 2 years has made me realise that combined profits from sales and dividends average £725 a month. Given that both main accounts are also up by over 10% on purchase price, maybe things are going better than I thought!

Also pretty stable. The green line has gone up less than the red because it includes cash, so the rise in value was already reflected last week when the dividend and tax rebate arrived.

Here's the crappy trading account after week 67

			Weekly Change
Cash	£79.63		+£0
Portfolio cost	£486.05		+£0
Portfolio sell value (bid price - commission)	£318.87	(-34.2%)	-£30.58
Potential profits	£0		+£0
Dividends	£1.15		+£0
Profit from sales	-£22.85		+£0
Average monthly cash profit	-£1.40	(-3.5%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

REDS:RedstoneConnect dropped by 6% following confirmation that the proposed buy-out wasn't really serious. All hope of getting rid of these any time soon has vanished so the torture continues.

Dire

Absolutely anything could happen this week. I'm actually quite excited as there seems to be gossip a-plenty. For a start the closing bid price for OPTI:Optibiotix was crazy given people were selling at above 73p so I'm hoping for an immediate tick up of at least a penny which would generate £450.

JLP:Jubilee Platinum could be interesting as we're approaching the date they usually give a trading update. LMI:Lonmin have announced they will be selling off some of their production capability, so JLP:Jubilee Platinum may possibly be tempted as they would be able to sell platinum rather than just concentrate.

The iPhone X has launched well, and that could drive IQE:IQE higher, particularly if the shorters decide now is the time to close.

KIBO:Kibo Mining now have the environmental and social certificates from the government which I was expecting to drive the price higher rather than a 4% drop, but these are really key documents. The RNS stated that now these are completed, the Memorandum of Understanding on the Power Purchase Agreement is progressing well and will be finalized shortly. Not sure how "short" shortly will be, but once that is done the construction of the power plant can begin.

AFPO:African Potash is trading again. That allowed the share bid price to drop from 0.02p to 0.01p which I'm really hoping is as low as it can go. If it moves to 0.0099p then I may fall into despair. My only hope is that they can get something for their potash mining licence, but with over 2 billion shares in issue, my 27,860 are not going to see much of the proceeds. I probably ought to resign myself to losing everything, which is £707 so not the end of the world.

What really scares me about this share is the optimism I had in the early days. Everything seemed so good, and all the right steps had been taken to make it seem one of the most exciting projects on AIM. Given the vast number of shares that changed hands, many people bought into the story. Unfortunately the ability to deliver any fertiliser to anyone failed completely and ended up with a warehouse full of the stuff that nobody would pay for.

My main lesson from this experience is to research the track record of the directors, and especially the CEO. Have they run successful companies before? A prime example is TLOU:Tlou Energy, with a CEO that has taken 2 companies to over a billion dollars. That gives me much more confidence that despite the project being risky, it's in good hands.

Just a few more hours and the excitement begins all over again...